Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Sunesis files IND for Aurora kinase inhibitor SNS-314

March 5, 2007

Insert and R&D sign agreement on second-generation epothilones

March 5, 2007

Point Therapeutics advances talabostat studies

March 5, 2007

EvoGenix and Vegenics collaborate on VEGF-D antibody therapeutic products

March 5, 2007

Promising results for HE-32356 in mouse models of hormone-refractory prostate and breast cancer

March 5, 2007

Recent patents impart novel therapeutics for the treatment of cancer

March 5, 2007

Tykerb studied in phase III trial for head and neck cancer

March 2, 2007

Davanat filed for E.U. orphan drug status, advancing in phase II trials

March 2, 2007

Fenretinide receives orphan drug designations in U.S. and E.U.

March 2, 2007

Alpharadin improves survival in hormone-refractory prostate cancer

March 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...